AdvaMed Urges CMS to Revise Proposed DME Competitive Bidding Rule
The medtech association cites risks to patient safety, reduced competition, and potential cost increases if the rule is implemented as is.
The medtech association cites risks to patient safety, reduced competition, and potential cost increases if the rule is implemented as is.
The medtech association cites risks to patient safety, reduced competition, and potential cost increases if the rule is implemented as is.